Shu‐Nan Qi

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial

Shu-Lian Wang, Hui Fang, Yong-Wen Song et al. · The Lancet Oncology · 2019 · 387 citations

Surgical Oncology, High-risk Breast Cancer, Breast Oncology +8

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi et al. · Leukemia · 2020 · 125 citations · Full text

Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China

Shu-Lian Wang, Hui Fang, Chen Hu et al. · Journal of Clinical Oncology · 2020 · 105 citations

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma

Yong Yang, Jian-Zhong Cao, Shengmin Lan et al. · JAMA Oncology · 2016 · 82 citations

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Shu‐Nan Qi, Yong Yang, Yu-Qin Song et al. · Blood Advances · 2020 · 56 citations · Full text